Stockscreener 앱 받기
4.852
6.33%
-0.328
전일 마감가:
$5.18
열려 있는:
$4.92
하루 거래량:
975
Relative Volume:
0.01
시가총액:
$6.82M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+19.21%
1개월 성능:
+2.15%
6개월 성능:
-53.18%
1년 성능:
-93.51%
1일 변동 폭
$4.92
$4.995
1주일 범위
$4.13
$5.30
52주 변동 폭
$3.61
$80.00
Advanced Biomed Inc Stock (ADVB) Company Profile
명칭
Advanced Biomed Inc
전화
86-21-20510823
주소
401 RYLAND ST, RENO
Compare ADVB vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVB
Advanced Biomed Inc
|
4.995 | 7.07M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
485.16 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.98 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
590.04 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
113.08 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
293.86 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Advanced Biomed Inc 주식(ADVB)의 최신 뉴스
Market Leaders: Whats the fair value of Advanced Biomed Inc stock2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Catalysts: Is Advanced Biomed Inc currently under institutional pressure2026 PreEarnings & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Dip Buying: What hedge funds are buying ProShares Trust ProShares Ultra FTSE EuropeJuly 2025 PreEarnings & Smart Money Movement Alerts - baoquankhu1.vn
Rally Mode: Should I hold or sell Advanced Biomed Inc nowDividend Hike & Low Risk Entry Point Guides - baoquankhu1.vn
Growth Report: Will JPMPRL benefit from government policyJuly 2025 Macro Moves & AI Enhanced Trading Alerts - baoquankhu1.vn
Aug Summary: Is Advanced Biomed Inc a strong candidate for buy and holdWeekly Profit Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Morning Market Movers: ALTO, GO, TTD, VCIG See Big Swings - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Risk On: Should value investors consider ACXPJuly 2025 Short Interest & Long Hold Capital Preservation Plans - baoquankhu1.vn
Surge for ADVB: New Partnerships and Market Strategies Drive Momentum - timothysykes.com
Advanced Biomed Executes Reverse Split to Maintain Nasdaq Listing - TipRanks
Advanced Biomed (NASDAQ: ADVB) completes 1-for-20 reverse stock split - Stock Titan
Volume Report: Is Columbus Acquisition Corp Debt Equity Composite Units stock a good pick for beginnersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Sentiment Review: Does GROY have strong fundamentalsPortfolio Update Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
How Advanced Biomed Inc. stock performs during Fed tightening cyclesWeekly Trading Summary & Expert Approved Trade Ideas - mfd.ru
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance By Investing.com - Investing.com South Africa
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation - 富途牛牛
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance - Investing.com Canada
Uber to invest over $100 million in autonomous vehicle charging amid robotaxi push - Bitget
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer - Bitget
Advanced Biomed Inc. Announces 1-for-20 Reverse Stock Split Effective February 20, 2026 - Quiver Quantitative
Advanced Biomed Inc. announces 1 for 20 share consolidation - marketscreener.com
Advanced Biomed Inc. Announces 1 For 20 Share Consolidation - TradingView
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Will Advanced Biomed Inc. stock deliver better than expected guidanceJuly 2025 Trade Ideas & Safe Swing Trade Setups - mfd.ru
Advanced Biomed Inc. SEC 10-Q Report - TradingView
Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusCIntegrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - The Manila Times
Nasus Pharma Announces Closing of $15.0 Million Private Placement - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study - GlobeNewswire
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - Sahm
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
IPO window reopens, med-tech class of 2025 gains 26% - BioWorld MedTech
Guidance Update: Does Prelude Therapeutics Incorporated have a sustainable dividend2025 Trading Recap & Smart Investment Allocation Insights - baoquankhu1.vn
Can Advanced Biomed Inc. outperform under higher oil pricesWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
Is Advanced Biomed Inc. a strong candidate for buy and holdJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - mfd.ru
Trading Action: Whats the fair value of Advanced Biomed Inc stock2025 Buyback Activity & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Advanced Biomed Completes Private Placement Equity Financing - TipRanks
Advanced Biomed Signs Securities Purchase Agreement With Certain Investors - TradingView
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aug Outlook: Can CCRN scale operations efficientlyJuly 2025 Outlook & Capital Efficiency Focused Strategies - baoquankhu1.vn
Advanced Biomed Inc. amends spin-off agreement, sets repayment terms for subsidiary - Investing.com India
Advanced Biomed (ADVB) Stock Trends and Sentiment 2026 - MarketBeat
Advanced Biomed Secures Repayment Terms in Hong Kong Spin-Off - TipRanks
Advanced Biomed Signs Supplemental Agreement With Wei Ha Hui - TradingView
Aug Patterns: Whats HTGCs historical return2025 Investor Takeaways & Low Risk Growth Stock Ideas - baoquankhu1.vn
FOMO Trade: What is EICBs 5 year growth outlookPortfolio Value Summary & Weekly High Conviction Ideas - baoquankhu1.vn
Big Money Moves: Is MicroSectors Travel 3X Leveraged ETNs due May 29 2042 showing insider buyingWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Gap Down: Is Seanergy Maritime Holdings Corp showing insider buying2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Advanced Biomed Inc (ADVB) 재무 분석
Advanced Biomed Inc (ADVB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.71%
0.97%
자본화:
|
볼륨(24시간):